Repigmentation of Tenacious Vitiligo on Apremilast
نویسندگان
چکیده
منابع مشابه
Repigmentation of Tenacious Vitiligo on Apremilast
Vitiligo is a common pigment disorder characterized by acquired loss of function or absence of melanocytes, leading to distinct areas of depigmentation. Physical exam reveals sharply demarcated, depigmented macules or patches on otherwise normal skin. Vitiligo can present at any age, in any skin color. There is no specific serologic marker for diagnosis, but patients often have other autoimmune...
متن کاملVitiligo Repigmentation: What’s New?
Vitiligo is a relatively common acquired skin disorder, characterized by the progressive loss of melanocytes, which results in white patches. Classically, vitiligo’s treatments have been considered unsatisfactory and challenging. Recent advances in the knowledge of vitiligo’s pathogenesis have contributed to find better therapeutic options, so that at present many patients find a solution for d...
متن کاملUpdate on skin repigmentation therapies in vitiligo.
Treatment for vitiligo is difficult and prolonged. Nevertheless, at present considerable knowledge accumulated during several decades on the pathogenic mechanisms, revealed important clues for designing new strategies to improve vitiligo depigmentation. With available medical therapies, high repigmentation percentages mostly on facial and neck lesions are achieved, although they are less effect...
متن کاملRepigmentation of vitiligo with autologous blister-induced epidermal grafts.
Treatment of vitiligo can sometimes be difficult and disappointing. PUVA treatments give fairly good results. However, acral regions like the hands or feet or areas over bony prominences like the elbow, are resistant to PUVA. Blister-induced epidermal grafts have been used to repigment vitiligo skin. This study was carried out on patients with vitiligo areas unresponsive to either PUVA treatmen...
متن کاملRepigmentation in a Vitiligo Universalis Patient: Chemotherapy-Induced or Spontaneous?
Vol. 29, No. 5, 2017 651 Received July 27, 2016, Revised September 22, 2016, Accepted for publication September 26, 2016 Corresponding author: Hei Sung Kim, Department of Dermatology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon 21431, Korea. Tel: 82-32-280-5100, Fax: 82-2-506-9514, E-mail: [email protected] This is ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports in Dermatological Medicine
سال: 2017
ISSN: 2090-6463,2090-6471
DOI: 10.1155/2017/2386234